Drugs / Autologous Regulatory Т-cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05214014 | Sep 2022 → Dec 2023 | systemic sclerosis | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous Regulatory Т-cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05214014 ↗ |
| Modality | Cell therapy | “Biological: Autologous Regulatory Т-cells” NCT05214014 ↗ |